Focus: Osteal Therapeutics is a public biotechnology company developing drug-device combination products focused on preventing prosthetic joint infections in the musculoskeletal space. The company operates as a focused, single-indication player in a specialized orthopedic market.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Cooling — net -9 jobs in 30d
0 added, 9 removed. Slower than typical.
Osteal is a pre-revenue, sharply focused public biotech with early-stage pipeline depth but extremely limited hiring activity—suitable only for scientists seeking a narrow, specialized role with Phase 2-stage exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Osteal Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Osteal Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles